Hizentra 200 mg/ml solution for subcutaneous injection, Privigen 100 mg/ml solution for infusion clinical trials

Randomized, parallel study of subcutaneous versus intravenous immunoglobulin in treatment-naïve patients with chronic inflammatory demyelinating polyneuropathy

This study compares two ways of giving an important medicine for a nerve condition called CIDP. One way is an injection under the skin, and the other is through a drip into a vein. It looks at how well each method improves daily activities and muscle strength.